Sagimet Biosciences (SGMT)

• Market cap: $121M
• 1 day: -4.81%
• 5 days: -5.53%
• 1 month: 4.16%
• 3 months: -23.89%
• 6 months: 33.33%
• Year to date: -16.26%
• 1 year: -34.38%
• 5 years: -76.43%
• 10 years: -76.43%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

44% more capital invested

Capital invested by funds: $54.6M [Q3] → $78.8M (+$24.1M) [Q4]

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

5% more funds holding

Funds holding: 63 [Q3] → 66 (+3) [Q4]

7.26% less ownership

Funds ownership: 64.31% [Q3] → 57.04% (-7.26%) [Q4]

25% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 20

33% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]

78% less call options, than puts

Call options by funds: $281K | Put options by funds: $1.26M

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $32 751% upside
• Avg. target: $37 884% upside
• High target: $42 1,017% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Ed Arce 47% 1-year accuracy 71 / 152 met price target	751% upside $32	Buy Reiterated	13 Mar 2025
Jones Trading Debanjana Chatterjee 50% 1-year accuracy 3 / 6 met price target	1,017% upside $42	Buy Initiated	27 Jan 2025